Article Text

PDF
CASE REPORT
Achromobacter xylosoxidans in idiopathic cystic bronchiectasis
  1. Anthony Simon Bates1,
  2. Manjula Natarajan2 and
  3. Raja Vongala Reddy3
  1. 1 Surgical Sciences MSc Student, University of Oxford
  2. 2 Departmemt of Microbiology, Kettering Hospital, Kettering, UK
  3. 3 Kettering Hospital, Kettering, UK
  1. Correspondence to Anthony Simon Bates, anthony.simon.bates{at}gmail.com

Abstract

This is the first case in the English language describing Achromobacter xylosoxidans in a patient with idiopathic bronchiectasis. A 66-year-old man with bronchiectasis presented with shortness of breath to the emergency department of our institution, a district hospital in the UK. His medications included long-term supplemental oxygen therapy and prophylactic azithromycin. Following 2 days admission to the respiratory unit, his saturations significantly deteriorated, and the patient was admitted to intensive care with type II respiratory failure. Following a week of intubation and ventilation, multidrug resistant A. xylosoxidans was isolated from the tracheal aspiration secretions. The patient recovered after receiving targeted intravenous antimicrobial therapy.

  • pneumonia (infectious disease)
  • adult intensive care
  • respiratory medicine
  • interstitial lung disease

Statistics from Altmetric.com

Footnotes

  • Contributors MN oversaw the microbiological management of the patient and revised drafts of the report. RVR edited and revised drafts of the report. ASB wrote the report.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.